CO5580773A2 - Rosuvastatina en estados pre dementes - Google Patents

Rosuvastatina en estados pre dementes

Info

Publication number
CO5580773A2
CO5580773A2 CO04035705A CO04035705A CO5580773A2 CO 5580773 A2 CO5580773 A2 CO 5580773A2 CO 04035705 A CO04035705 A CO 04035705A CO 04035705 A CO04035705 A CO 04035705A CO 5580773 A2 CO5580773 A2 CO 5580773A2
Authority
CO
Colombia
Prior art keywords
rosuvastatina
dement
states
patient
dementia
Prior art date
Application number
CO04035705A
Other languages
English (en)
Spanish (es)
Inventor
Hans Basun
Timothy PISER
Ihor Rak
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of CO5580773A2 publication Critical patent/CO5580773A2/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrane Compounds (AREA)
CO04035705A 2001-10-19 2004-04-19 Rosuvastatina en estados pre dementes CO5580773A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0103509A SE0103509D0 (sv) 2001-10-19 2001-10-19 Rosuvastatin in pre demented states

Publications (1)

Publication Number Publication Date
CO5580773A2 true CO5580773A2 (es) 2005-11-30

Family

ID=20285721

Family Applications (1)

Application Number Title Priority Date Filing Date
CO04035705A CO5580773A2 (es) 2001-10-19 2004-04-19 Rosuvastatina en estados pre dementes

Country Status (19)

Country Link
US (1) US20060229321A1 (https=)
EP (1) EP1446123A1 (https=)
JP (1) JP2005505605A (https=)
KR (1) KR20040058201A (https=)
CN (1) CN1604780A (https=)
AR (1) AR036891A1 (https=)
BR (1) BR0213434A (https=)
CA (1) CA2463597A1 (https=)
CO (1) CO5580773A2 (https=)
HU (1) HUP0401798A3 (https=)
IL (1) IL161380A0 (https=)
IS (1) IS7218A (https=)
MX (1) MXPA04003631A (https=)
NO (1) NO20041840L (https=)
PL (1) PL369573A1 (https=)
RU (1) RU2004112422A (https=)
SE (1) SE0103509D0 (https=)
WO (1) WO2003032995A1 (https=)
ZA (1) ZA200402844B (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005023778A2 (en) 2003-08-28 2005-03-17 Teva Pharmaceutical Industries Ltd. Process for preparation of rosuvastatin calcium
GB0322552D0 (en) 2003-09-26 2003-10-29 Astrazeneca Uk Ltd Therapeutic treatment
EP1601658A1 (en) 2003-11-24 2005-12-07 Teva Pharmaceutical Industries Limited Crystalline ammonium salts of rosuvastatin
US7244844B2 (en) 2003-12-02 2007-07-17 Teva Pharmaceutical Industries Ltd. Reference standard for characterization of rosuvastatin
WO2006017357A1 (en) 2004-07-13 2006-02-16 Teva Pharmaceutical Industries Ltd. A process for the preparation of rosuvastatin involving a tempo-mediated oxidation step
KR101020024B1 (ko) 2005-02-22 2011-03-09 테바 파마슈티컬 인더스트리즈 리미티드 로수바스타틴 알킬에테르를 함유하지 않는 로수바스타틴 및이의 염 및 이의 제조 방법
WO2007022488A2 (en) 2005-08-16 2007-02-22 Teva Pharmaceutical Industries Ltd. Crystalline rosuvastatin intermediate
WO2012073256A1 (en) 2010-11-29 2012-06-07 Cadila Healthcare Limited Salts of rosuvastatin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2648897B2 (ja) * 1991-07-01 1997-09-03 塩野義製薬株式会社 ピリミジン誘導体
US7189703B2 (en) * 1998-01-09 2007-03-13 Intracell, Llc Treatment and diagnosis of alzheimer's disease
AR022462A1 (es) * 1999-02-06 2002-09-04 Astrazeneca Uk Ltd Uso de un agente que disminuye el colesterol
US20030100493A1 (en) * 2001-07-19 2003-05-29 Sol Weiss Sublingual use of inhibitors in the biosynthesis of cholesterol

Also Published As

Publication number Publication date
WO2003032995A8 (en) 2004-06-03
IL161380A0 (en) 2004-09-27
AR036891A1 (es) 2004-10-13
CA2463597A1 (en) 2003-04-24
IS7218A (is) 2004-04-13
HUP0401798A2 (hu) 2005-01-28
KR20040058201A (ko) 2004-07-03
EP1446123A1 (en) 2004-08-18
BR0213434A (pt) 2004-11-09
CN1604780A (zh) 2005-04-06
PL369573A1 (en) 2005-05-02
HUP0401798A3 (en) 2005-06-28
WO2003032995A1 (en) 2003-04-24
SE0103509D0 (sv) 2001-10-19
MXPA04003631A (es) 2004-07-30
JP2005505605A (ja) 2005-02-24
US20060229321A1 (en) 2006-10-12
NO20041840L (no) 2004-05-05
RU2004112422A (ru) 2005-04-10
ZA200402844B (en) 2005-01-24

Similar Documents

Publication Publication Date Title
BR0113200A (pt) Combinação terapêutica
EA200100572A1 (ru) Способ применения ингибитора циклооксигеназы-2 и одного или нескольких противоопухолевых лекарственных средств в качестве комбинированного способа лечебного воздействия при лечении неоплазии
PT840601E (pt) Thip para o tratamento de desordens do sono
FI973868A7 (fi) D2-vitamiini- tai D4-vitamiinijohdannaisten käyttö sekundaarisen hyper paratyreoosin hoitoon tarkoitettu lääkkeen valmistuksessa
CY1108725T1 (el) Συνδυασμος ανταγωνιστου-nmda και αναστολεων ακετυλοχολινεστερασης δια την θεραπειαν της νοσου alzheimer
BRPI0111116B8 (pt) imitadores de trombopoietina
DK0695189T3 (da) Behandling af inflammatorisk tarmsygdom med IFN-gammainhibitorer
DE60215787D1 (de) Behandlung von typ ii diabetes mit dipeptidyl-peptidase-iv-hemmern
MX9700082A (es) Composicion que consiste de morfina, polipirrolidona y oxido de polialquileno.
CY2010005I1 (el) Αναστολεις της κυκλοπροπυλ-συντηκωμενης διπεπτυλοπεπτιδασης 4, βασισμενοι σε πυρρολιδινη, και μεθοδοι για την παρασκευη των και την χρηση των
BR0111913A (pt) Análogos de gabapentina para distúrbios do sono
DK0998287T3 (da) Anvendelse af levobupivacain
GB0002336D0 (en) Medicaments
BR0110506A (pt) Uso de inibidores de il-18 para o tratamento e/ou prevenção da aterosclerose
CO5580773A2 (es) Rosuvastatina en estados pre dementes
MX9400630A (es) 6-cloro-5-fluoro-3-(2-tenoil)-2-oxindol-1-carboxamida como un agente analgesico y antiinflamatorio.
BR9811937A (pt) Método de aumentar a biodisponibilidade de fexofenadina e de seus derivados
BR9809673A (pt) Derivados de triptolida úteis no tratamento de doenças autoimunes
UY26171A1 (es) Método y formulación farmacéutica para el tratamiento de la discinesia de aparición tardía
MX9403032A (es) Quinolil-dihidropiridinas condensadas, procedimiento para su fabricacion ysu uso en medicamentos.
BR0016941A (pt) Derivados de aminometil-fenil-ciclohexanona
BR9910185A (pt) Uso de um composto, e, processo para o tratamento de um paciente que sofre de, ou em risco de, uma doença micobacteriana
BR0313230A (pt) Uso de carboxamidas para o tratamento de tinido
BR9809376A (pt) Pregnan-3-ol-20-onas
CO5590922A2 (es) Uso de istradefilina (kw-6002) para el tratamiento de trastornos de la conducta

Legal Events

Date Code Title Description
FA Application withdrawn